Technical Analysis for GBIO - Generation Bio Co.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Pocket Pivot | Bullish Swing Setup | -4.21% | |
Wide Bands | Range Expansion | -4.21% | |
Hammer Candlestick | Bullish | -0.34% | |
NR7 | Range Contraction | -0.34% | |
Wide Bands | Range Expansion | -0.34% | |
Down 3 Days in a Row | Weakness | -0.34% | |
Down 4 Days in a Row | Weakness | -0.34% |
Alert | Time |
---|---|
Possible NR7 | about 14 hours ago |
Possible Inside Day | about 14 hours ago |
60 Minute Opening Range Breakdown | about 16 hours ago |
Down 3% | about 16 hours ago |
Fell Below 10 DMA | about 17 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 02/21/2024
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.98 |
52 Week Low | 0.86 |
Average Volume | 267,810 |
200-Day Moving Average | 3.14 |
50-Day Moving Average | 2.22 |
20-Day Moving Average | 2.68 |
10-Day Moving Average | 3.04 |
Average True Range | 0.25 |
RSI (14) | 60.00 |
ADX | 49.62 |
+DI | 31.47 |
-DI | 10.36 |
Chandelier Exit (Long, 3 ATRs) | 2.96 |
Chandelier Exit (Short, 3 ATRs) | 2.69 |
Upper Bollinger Bands | 3.54 |
Lower Bollinger Band | 1.83 |
Percent B (%b) | 0.66 |
BandWidth | 63.65 |
MACD Line | 0.28 |
MACD Signal Line | 0.27 |
MACD Histogram | 0.0037 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.21 | ||||
Resistance 3 (R3) | 3.23 | 3.17 | 3.16 | ||
Resistance 2 (R2) | 3.17 | 3.11 | 3.16 | 3.15 | |
Resistance 1 (R1) | 3.06 | 3.07 | 3.04 | 3.04 | 3.14 |
Pivot Point | 3.01 | 3.01 | 2.99 | 2.99 | 3.01 |
Support 1 (S1) | 2.90 | 2.94 | 2.87 | 2.88 | 2.78 |
Support 2 (S2) | 2.84 | 2.90 | 2.83 | 2.77 | |
Support 3 (S3) | 2.74 | 2.84 | 2.76 | ||
Support 4 (S4) | 2.71 |